Hypertension

On Wear Red Day, Dr. Ivanova advocates for increased awareness and diversity in women's cardiovascular care.

Rates of aspirin use for preeclampsia prophylaxis were observed in a minority of women with risk factors including pre-pregnancy diabetes, obesity, or chronic hypertension.

An analysis of the National Inpatient Sample suggests the rates of hospitalization for hypertension crises increased from 2002 to 2015, but the rate of in-hospital death during these crises decreased during the same period.

There was not an association between sleep duration and metabolic diseases found in men.

The new guidelines conclude that current evidence is insufficient to assess the balance of benefits and harms of screening for AF in adults ≥50 years.

Early-pregnancy NT-proBNP level may be an important determinant of pregnancy outcomes and CV risk.

A recent analysis of data from more than 4000 women suggests higher NT-proBNP concentrations during early pregnancy were associated with a 19% reduction in risk of HDP and a 16% reduction in risk of hypertension 2-7 years after delivery.

Data show the change in CHD prevalence from 2011 - 2018 (6.2% to 6.0%) was statistically insignificant.

Data show among patients with focal FDG uptake, PET/MRI and inflammatory blood markers resolved at follow-up performed at a mean of 52 days after baseline.

A retrospective cohort analysis of more than 3000 patients with CKD suggests use of MRAs was significantly associated with a reduction in the need for renal replacement therapy.

Data show the 1-year incidence of the composite primary endpoint was 10.6% among patients randomized to FFR-guided PCI and 6.9% in CABG.

Sexual activity was involved in 0.2% of all SCDs, with sudden arrhythmic death syndrome and cardiomyopathies predominant underlying causes.

Abbott's device is designed to create highly detailed 3-dimensional maps of the heart to help physicians identify and treat abnormal rhythms.

Data show Black and White patients had a similar risk of MACE over a median 24.4-month follow-up.

From the pooled results of TRILOGY 1 and 2, data show 4 g/d of ω-3–PL/FFA reduced TG levels by 10.9% at 12 weeks and 12.7% at 26 weeks, relative to placebo.

A recent analysis found patients with benign adrenal tumors and MACS were at an increased risk of cardiometabolic diseases.

In comparison to men, women with ASCVD were more likely to report being clinically depressed, have cost-related medication nonadherence, and have not seen a physician due to cost.

Each month, our editorial staff compiles a month in review highlighting the most popular content from the past month. December's month in review features new guidelines, FDA news, and more.

Released on Dec. 15, the latest scientific statement from the American Heart Association provides a comprehensive overview of the available evidence on topics related to diagnosis, management, and pharmacotherapy for hypertension during pregnancy.

The Practical Cardiology editorial staff has compiled a list of 6 noteworthy posters related to cardiology from the Metabolic Institute of America's 19th annual World Congress on Insulin Resistance, Diabetes, and Cardiovascular Disease.

A report published in Circulation details per month increases in both systolic and diastolic blood pressure observed during the pandemic as compared with prepandemic periods.

Obesity is a risk factor for both obstructed sleep apnea and IHH.

Data show the absolute risk difference for the development of PPHN after exposure to antidepressants in late pregnancy was 1.3 per 1000 infants.

Data show the multivariable-adjusted HR for increase in seafood consumption of 1 oz per day and all-cause mortality was 0.84 and for CVD-related mortality was 0.89.

Study data show for each $1,000 decrease in median household income, the number of TAVR procedures performed per 100,000 Medicare beneficiaries was 0.2% lower.